These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30650541)

  • 1. Protein Corona Fingerprints of Liposomes: New Opportunities for Targeted Drug Delivery and Early Detection in Pancreatic Cancer.
    Palchetti S; Caputo D; Digiacomo L; Capriotti AL; Coppola R; Pozzi D; Caracciolo G
    Pharmaceutics; 2019 Jan; 11(1):. PubMed ID: 30650541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinically approved PEGylated nanoparticles are covered by a protein corona that boosts the uptake by cancer cells.
    Papi M; Caputo D; Palmieri V; Coppola R; Palchetti S; Bugli F; Martini C; Digiacomo L; Pozzi D; Caracciolo G
    Nanoscale; 2017 Jul; 9(29):10327-10334. PubMed ID: 28702661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Biomolecular Corona of Liposomal Doxorubicin: The Overlooked Factor in Anticancer Drug Delivery.
    Caracciolo G; Palchetti S; Digiacomo L; Chiozzi RZZ; Capriotti AL; Amenitsch H; Tentori PM; Palmieri V; Papi M; Cardarelli F; Pozzi D; Laganà A
    ACS Appl Mater Interfaces; 2018 Jul; 10(27):22951-22962. PubMed ID: 29905462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain Targeting by Liposome-Biomolecular Corona Boosts Anticancer Efficacy of Temozolomide in Glioblastoma Cells.
    Arcella A; Palchetti S; Digiacomo L; Pozzi D; Capriotti AL; Frati L; Oliva MA; Tsaouli G; Rota R; Screpanti I; Mahmoudi M; Caracciolo G
    ACS Chem Neurosci; 2018 Dec; 9(12):3166-3174. PubMed ID: 30015470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Glucose on Liposome-Plasma Protein Interactions: Relevance for the Physiological Response of Clinically Approved Liposomal Formulations.
    Palchetti S; Digiacomo L; Pozzi D; Zenezini Chiozzi R; Capriotti AL; Laganà A; Coppola R; Caputo D; Sharifzadeh M; Mahmoudi M; Caracciolo G
    Adv Biosyst; 2019 Feb; 3(2):e1800221. PubMed ID: 32627369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized Graphene Oxide-Protein Corona in the Human Plasma of Pancreatic Cancer Patients.
    Di Santo R; Digiacomo L; Quagliarini E; Capriotti AL; Laganà A; Zenezini Chiozzi R; Caputo D; Cascone C; Coppola R; Pozzi D; Caracciolo G
    Front Bioeng Biotechnol; 2020; 8():491. PubMed ID: 32523944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-circulating magnetoliposomes as surrogates for assessing pancreatic tumour permeability and nanoparticle deposition.
    Moloney C; Roy Chaudhuri T; Spernyak JA; Straubinger RM; Brougham DF
    Acta Biomater; 2023 Mar; 158():611-624. PubMed ID: 36603732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting the Growth of 3D Brain Cancer Models with Bio-Coronated Liposomal Temozolomide.
    Perini G; Giulimondi F; Palmieri V; Augello A; Digiacomo L; Quagliarini E; Pozzi D; Papi M; Caracciolo G
    Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33809262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplexed Detection of Pancreatic Cancer by Combining a Nanoparticle-Enabled Blood Test and Plasma Levels of Acute-Phase Proteins.
    Caputo D; Coppola A; Quagliarini E; Di Santo R; Capriotti AL; Cammarata R; Laganà A; Papi M; Digiacomo L; Coppola R; Pozzi D; Caracciolo G
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protein corona of circulating PEGylated liposomes.
    Palchetti S; Colapicchioni V; Digiacomo L; Caracciolo G; Pozzi D; Capriotti AL; La Barbera G; Laganà A
    Biochim Biophys Acta; 2016 Feb; 1858(2):189-96. PubMed ID: 26607013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the accuracy of pancreatic cancer clinical staging by exploitation of nanoparticle-blood interactions: A pilot study.
    Caputo D; Cartillone M; Cascone C; Pozzi D; Digiacomo L; Palchetti S; Caracciolo G; Coppola R
    Pancreatology; 2018 Sep; 18(6):661-665. PubMed ID: 29914752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The liposome-protein corona in mice and humans and its implications for in vivo delivery.
    Caracciolo G; Pozzi D; Capriotti AL; Cavaliere C; Piovesana S; La Barbera G; Amici A; Laganà A
    J Mater Chem B; 2014 Nov; 2(42):7419-7428. PubMed ID: 32261967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs.
    Milano G; Innocenti F; Minami H
    Cancer Sci; 2022 Jul; 113(7):2224-2231. PubMed ID: 35445479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically approved liposomal nanomedicines: lessons learned from the biomolecular corona.
    Caracciolo G
    Nanoscale; 2018 Mar; 10(9):4167-4172. PubMed ID: 29450412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuning liposome composition to modulate corona formation in human serum and cellular uptake.
    Yang K; Mesquita B; Horvatovich P; Salvati A
    Acta Biomater; 2020 Apr; 106():314-327. PubMed ID: 32081780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal Targeted Nanoparticle-Based Delivery System for Pancreatic Tumor Imaging in Cellular and Animal Models.
    Medina OP; Tower RJ; Medina TP; Ashkenani F; Appold L; Bötcher M; Huber L; Will O; Ling Q; Hauser C; Rohwedder A; Heneweer C; Peschke E; Hövener JB; Lüdtke-Buzug K; Boretius S; Mentlein R; Kairemo K; Glüer CC; Sebens S; Kalthoff H
    Curr Pharm Des; 2022; 28(4):313-323. PubMed ID: 32679012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Liposomal Formulation of Baicalein for the Treatment of Pancreatic Ductal Adenocarcinoma: Design, Characterization, and Evaluation.
    Markowski A; Zaremba-Czogalla M; Jaromin A; Olczak E; Zygmunt A; Etezadi H; Boyd BJ; Gubernator J
    Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized liposome-protein corona in the blood of breast, gastric and pancreatic cancer patients.
    Colapicchioni V; Tilio M; Digiacomo L; Gambini V; Palchetti S; Marchini C; Pozzi D; Occhipinti S; Amici A; Caracciolo G
    Int J Biochem Cell Biol; 2016 Jun; 75():180-7. PubMed ID: 26369869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of doxorubicin liposomal formulations for size-based distribution of drug and excipients using asymmetric-flow field-flow fractionation (AF4) and liquid chromatography-mass spectrometry (LC-MS).
    Ansar SM; Mudalige T
    Int J Pharm; 2020 Jan; 574():118906. PubMed ID: 31805309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence Lifetime Nanoscopy of Liposomal Irinotecan Onivyde: From Manufacturing to Intracellular Processing.
    Bernardi M; Signore G; Moscardini A; Pugliese LA; Pesce L; Beltram F; Cardarelli F
    ACS Appl Bio Mater; 2023 Oct; 6(10):4277-4289. PubMed ID: 37699572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.